Leem adds board members
This article was originally published in Scrip
Leem, the French pharmaceutical industry association, has made Jean Scheftsik de Szolnok, president of Boehringer Ingelheim France, a member of its board of directors. Dr Robert Dahan, CEO of AstraZeneca France has become a vice-president, and Dr Patrice Zagamé, CEO of Novartis France, has been made an officer. The appointees will replace Dominque Mangeot on the board.